The U.S. Food and Drug Administration (FDA) recently withheld approval for a novel once-a-month injection designed to treat relapsing forms of multiple sclerosis (MS), a severe neurological disorder. This decision impacts the
More
The U.S. Food and Drug Administration (FDA) recently withheld approval for a novel once-a-month injection designed to treat relapsing forms of multiple sclerosis (MS), a severe neurological disorder. This decision impacts the
More